Skip to main content
. 2022 Sep 16;27(12):1004–e926. doi: 10.1093/oncolo/oyac185

Figure 2.

Figure 2.

Inhibition of the phosphatidylinositol-3 kinase pathway using bimiralisib in loss-of-function NOTCH1-mutant head and neck cancer.